Literature DB >> 18316520

Persistence of Borrelia burgdorferi following antibiotic treatment in mice.

Emir Hodzic1, Sunlian Feng, Kevin Holden, Kimberly J Freet, Stephen W Barthold.   

Abstract

The effectiveness of antibiotic treatment was examined in a mouse model of Lyme borreliosis. Mice were treated with ceftriaxone or saline solution for 1 month, commencing during the early (3 weeks) or chronic (4 months) stages of infection with Borrelia burgdorferi. Tissues from mice were tested for infection by culture, PCR, xenodiagnosis, and transplantation of allografts at 1 and 3 months after completion of treatment. In addition, tissues were examined for the presence of spirochetes by immunohistochemistry. In contrast to saline solution-treated mice, mice treated with antibiotic were consistently culture negative, but tissues from some of the mice remained PCR positive, and spirochetes could be visualized in collagen-rich tissues. Furthermore, when some of the antibiotic-treated mice were fed on by Ixodes scapularis ticks (xenodiagnosis), spirochetes were acquired by the ticks, as determined based upon PCR results, and ticks from those cohorts transmitted spirochetes to naïve SCID mice, which became PCR positive but culture negative. Results indicated that following antibiotic treatment, mice remained infected with nondividing but infectious spirochetes, particularly when antibiotic treatment was commenced during the chronic stage of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316520      PMCID: PMC2346637          DOI: 10.1128/AAC.01050-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  69 in total

1.  Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.

Authors:  Linda K Bockenstedt; Jialing Mao; Emir Hodzic; Stephen W Barthold; Durland Fish
Journal:  J Infect Dis       Date:  2002-10-23       Impact factor: 5.226

2.  In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.

Authors:  Martin Sicklinger; Ralf Wienecke; Uwe Neubert
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.

Authors:  S Feng; E Hodzic; S W Barthold
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Erythromycin resistance in Borrelia burgdorferi.

Authors:  Darya Terekhova; Marina L Sartakova; Gary P Wormser; Ira Schwartz; Felipe C Cabello
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1.

Authors:  M Labandeira-Rey; J T Skare
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI.

Authors:  J V McDowell; S Y Sung; M Labandeira-Rey; J T Skare; R T Marconi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms.

Authors:  Maria Labandeira-Rey; J Seshu; Jonathan T Skare
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host.

Authors:  Joye E Purser; Matthew B Lawrenz; Melissa J Caimano; Jerrilyn K Howell; Justin D Radolf; Steven J Norris
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

10.  Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface.

Authors:  Emir Hodzic; Sunlian Feng; Kimberly J Freet; Dori L Borjesson; Stephen W Barthold
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  90 in total

1.  Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis.

Authors:  Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Remains of infection.

Authors:  Alan Barbour
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

3.  Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Authors:  Linda K Bockenstedt; David G Gonzalez; Ann M Haberman; Alexia A Belperron
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

4.  Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.

Authors:  Charles S Pavia; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

5.  Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research.

Authors:  Monica E Embers; Britton J Grasperge; Mary B Jacobs; Mario T Philipp
Journal:  J Vis Exp       Date:  2013-08-31       Impact factor: 1.355

6.  CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis.

Authors:  Bikash Sahay; Anju Singh; Arumugam Gnanamani; Rebeca L Patsey; J Edwin Blalock; Timothy J Sellati
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 7.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

8.  In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Authors:  Kristina Morgenstern; Georg Baljer; Douglas E Norris; Peter Kraiczy; Christa Hanssen-Hübner; Klaus-Peter Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Authors:  Adriana Marques; Sam R Telford; Siu-Ping Turk; Erin Chung; Carla Williams; Kenneth Dardick; Peter J Krause; Christina Brandeburg; Christopher D Crowder; Heather E Carolan; Mark W Eshoo; Pamela A Shaw; Linden T Hu
Journal:  Clin Infect Dis       Date:  2014-02-11       Impact factor: 9.079

Review 10.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.